---
schema_version: "secwatch.filing_event.v1"
accession: "0001690585-26-000026"
form_type: "8-K"
ticker: "DNTH"
cik: "0001690585"
company_name: "Dianthus Therapeutics, Inc. /DE/"
filed_at: "2026-05-22T20:10:16+00:00"
generated_at: "2026-05-22T20:12:56.302854+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Dianthus stockholders elect directors, approve say-on-pay, ratify Deloitte at 2026 annual meeting

## Summary
- Sujay Kango, Anne McGeorge, and Jonathan Violin elected Class II directors with 42.7M, 34.8M, and 42.8M votes for, respectively.
- Advisory vote on executive compensation passed: 41.0M for, 1.7M against, 0.5M abstain, 3.6M broker non-votes.
- Ratification of Deloitte & Touche as auditor for 2026 approved: 46.3M for, 5.3K against, 0.5M abstain, no broker non-votes.
- All three proposals passed with substantial majorities; no material changes to governance disclosed.

## SEC filing metadata
- accession: 0001690585-26-000026
- form_type: 8-K
- ticker: DNTH
- cik: 0001690585
- company_name: Dianthus Therapeutics, Inc. /DE/
- filed_at: 2026-05-22T20:10:16+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690585/000169058526000026/0001690585-26-000026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690585/000169058526000026/dnth-20260521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001690585-26-000026
- JSON: https://secwatch.observer/filing/0001690585-26-000026.json
- Plain text: https://secwatch.observer/filing/0001690585-26-000026.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.